Nasdaq
ALLO
Allogene Therapeutics, Inc.
- Health Care
- Listed 2018
- 1 day
- +1.0%
- 1 month
- −8.4%
- 1 year
- +85.8%
$1.97 · Mkt cap $680M
At the 6 Aug 2026 close
Nasdaq
Allogene Therapeutics, Inc.
$1.97 · Mkt cap $680M
At the 6 Aug 2026 close
Allogene Therapeutics, Inc. trades under the ticker ALLO on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2018. Its market capitalisation is $680M. The last closing price was $1.97, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +85.8%, and −8.4% over the past month. Returns are price returns and exclude dividends.
This page exists because ALLO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.